Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621619 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen as an Analgesic Adjunct
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT02621619 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 159 participants.
The verdict
NCT02621619, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
To determine the efficacy of intravenous (IV) acetaminophen as an analgesic adjunct to IV hydromorphone in the treatment of acute severe pain in the elderly Emergency Department (ED) patients.
Interventions
- DRUG IV acetaminophen + 0.5 mg IV hydromorphone
- DRUG Normal saline + 0.5 mg IV hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02621619
The ClinicalTrials.gov registry entry for NCT02621619 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IV acetaminophen + 0.5 mg IV hydromorphone is the first listed.
NCT02621619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02621619 about?
NCT02621619 is a clinical study titled "IV Acetaminophen as an Analgesic Adjunct". To determine the efficacy of intravenous (IV) acetaminophen as an analgesic adjunct to IV hydromorphone in the treatment of acute severe pain in the elderly Emergency Department (ED) patients.
What is the current status of trial NCT02621619?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 2016-03. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02621619?
The interventions under investigation include: IV acetaminophen + 0.5 mg IV hydromorphone (DRUG), Normal saline + 0.5 mg IV hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02621619?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.